APOH and Thrombocytopenia: Fu et al. reported a significantly higher platelet aggregation and activation in patients with thrombocytopenia than those without thrombocytopenia, which might be associated with reduced β2GPI levels due to the presence of anti-β2GPI IgG antibodies [76].